Literature DB >> 2509130

Economics of epoetin therapy.

A M Grimm1, K K Flaharty, L E Hopkins, J Mauskopf, A Besarab, P H Vlasses.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2509130

Source DB:  PubMed          Journal:  Clin Pharm        ISSN： 0278-2677


× No keyword cloud information.
  3 in total

Review 1.  Pharmacoeconomics of genetically engineered drugs.

Authors:  A J Jones-Grizzle; J L Bootman
Journal:  Pharmacoeconomics       Date:  1992-01       Impact factor: 4.981

Review 2.  Low-dosage epoetin in maintenance haemodialysis: costs and quality-of-life improvement.

Authors:  D C Harris
Journal:  Pharmacoeconomics       Date:  1994-01       Impact factor: 4.981

Review 3.  Epoetin: a pharmacoeconomic review of its use in chronic renal failure and its effects on quality of life.

Authors:  R Whittington; L B Barradell; P Benfield
Journal:  Pharmacoeconomics       Date:  1993-01       Impact factor: 4.981
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.